Ledger.Open graph →
SEC Form D · filed August 29, 2022

Vigil Neuroscience, Inc

Offering
$75.0M
Sold
$75.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Ivana Magovcevic-Liebisch · Cambridge, MAExec · DirectorMary Thistle · Mansfield, MADirectorSuzanne Bruhn · CAMBRIDGE, MADirectorBruce Booth · Waltham, MADirectorChristopher Verni · CAMBRIDGE, MAExecStefan Vitorovic · Boston, MADirectorEvan Thackaberry · CAMBRIDGE, MAExecCheryl Blanchard · Woburn, MADirectorGerhard Koenig · Cambridge, MADirectorSpyros Papapetropoulos · CAMBRIDGE, MAExecJennifer Ziolkowski · Cambridge, MAExecShaan Gandhi · Durham, NCDirectorBruce Booth · Cambridge, MADirectorIvana Magovcevic-Liebisch · Cambridge, MAExec · DirectorChristopher Verni · CAMBRIDGE, MAExecMary Thistle · Mansfield, MADirectorStefan Vitorovic · Boston, MADirectorEvan Thackaberry · CAMBRIDGE, MAExecCheryl Blanchard · Woburn, MADirectorSuzanne Bruhn · CAMBRIDGE, MADirectorGerhard Koenig · Cambridge, MADirectorSpyros Papapetropoulos · CAMBRIDGE, MAExecJennifer Ziolkowski · Cambridge, MAExecShaan Gandhi · Durham, NCDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗